Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
US8461191B2 · kind B2 · utility
1Cited by
4References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 2010 |
| Grant date | Jun 11, 2013 |
| Priority date | — |
| Expiry date | Nov 30, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
One aspect of the present invention relates to heterocyclic compounds that bind to bcl proteins and inhibit Bcl function. Another aspect of the present invention relates to compositions comprising a heterocyclic compound of the invention. The present invention provides methods for treating and modulating disorders associated with hyperproliferation, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.